PCVX logo

PCVXVaxcyte Inc

$47.36
$1.40
(2.87%)
Today
Closed $47.36
$0.36
(0.76%)
After Hours
Updated: 05:32 PM EDT
EarningsAug 5
Mkt Cap$6.84B
Vol1.11M
News
all
press releases
Vaxcyte (NASDAQ:PCVX) Stock Price Down 6.8% - What's Next?
Vaxcyte (NASDAQ:PCVX) Stock Price Down 6.8% - Should You Sell...
MarketBeat
News Placeholder
More News
News Placeholder
Jennison Associates LLC Has $31.26 Million Stock Position in Vaxcyte, Inc. $PCVX
Jennison Associates LLC trimmed its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 42.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 677,553 shares of the company's stock after selling 493...
MarketBeat
News Placeholder
Vaxcyte (NASDAQ:PCVX) COO Sells $127,867.50 in Stock
Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) COO Jim Wassil sold 2,250 shares of the stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $56.83, for a total transaction of $127,867.50. Following the completion of the sale, the chief operating officer owned...
MarketBeat
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Raises Stake in Vaxcyte, Inc. $PCVX
Universal Beteiligungs und Servicegesellschaft mbH boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 105.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 70,124 shares of the company...
MarketBeat
News Placeholder
Pictet Asset Management Holding SA Has $40.67 Million Stock Position in Vaxcyte, Inc. $PCVX
Pictet Asset Management Holding SA reduced its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 14.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 881,435 shares of the company's stock after se...
MarketBeat
News Placeholder
Vaxcyte (NASDAQ:PCVX) Rating Lowered to Strong Sell at Wall Street Zen
Wall Street Zen downgraded shares of Vaxcyte from a "sell" rating to a "strong sell" rating in a report on Tuesday...
MarketBeat
News Placeholder
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) have earned an average rating of "Moderate Buy" from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assig...
MarketBeat
News Placeholder
Vaxcyte (NASDAQ:PCVX) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of Vaxcyte from a "strong sell" rating to a "sell" rating in a research report on Monday...
MarketBeat
News Placeholder
Vaxcyte (NASDAQ:PCVX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of Vaxcyte from a "sell" rating to a "strong sell" rating in a report on Sunday...
MarketBeat
News Placeholder
Insider Selling: Vaxcyte (NASDAQ:PCVX) CAO Sells 3,000 Shares of Stock
Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CAO Elvia Cowan sold 3,000 shares of the business's stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price of...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.